×
ADVERTISEMENT

inavolisib

Itovebi With Palbociclib and Fulvestrant Approved for Some Advanced Breast Cancer Patients

The FDA has approved inavolisib (Itovebi, Genentech) with palbociclib and fulvestrant for adults with ...

OCTOBER 11, 2024

Load more